The results, while modest, were consistent with the peptide's selective mechanism.[4] The peptide appeared especially useful in the study for mobilizing visceral and abdominal fat the type most resistant to traditional diet and exercise
Obviously, the $$$ grubbing business weasels who sell pharmaceuticals would prefer you throw them out and fork-over for "new ones"
people at higher risk of deficiency include older adults, those with gastrointestinal issues that impair absorption, people whove had gastric surgery, long-term strict vegans who do not supplement, and those on certain acid-reducing medicines
The Phase 2 clinical trial showed approximately 2-3 kg of additional fat loss compared to placebo over 12 weeks
While this is often considered a secondary benefit, its an important part of the peptides overall metabolic profile